5 assets in Bone Neoplasm

Therapeutic assets addressing Bone Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Irinotecan Bone Neoplasm	Actuate Therapeutics Inc.	P3	BB (66)
Adriamycin Bone Neoplasm	Actuate Therapeutics Inc.	P2	CCC (53)
Carboplatin Bone Neoplasm	Actuate Therapeutics Inc.	P2	CCC (53)
Lomustine Bone Neoplasm	Actuate Therapeutics Inc.	P2	CCC (53)
Elraglusib Bone Neoplasm	Actuate Therapeutics Inc.	P2	CCC (50)